Quinsam Capital Corporation (FRA:0Q4)
Germany · Delayed Price · Currency is EUR | Market Cap | 2.92M +1.4% |
| Revenue (ttm) | 1.79M |
| Net Income | 1.44M |
| EPS | 0.02 |
| Shares Out | n/a |
| PE Ratio | 1.50 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 736,000 |
| Open | 0.0260 |
| Previous Close | 0.0260 |
| Day's Range | 0.0240 - 0.0260 |
| 52-Week Range | 0.0150 - 0.0515 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About Quinsam Capital
Quinsam Capital Corporation operates as an investment and merchant banking firm in Canada. It focuses small cap investments. The company is based in Toronto, Canada. [Read more]
News
Quinsam Capital Earnings Call Transcript: Q2 2026
Second quarter delivered modest profits and continued share buybacks, with a positive Q3 outlook driven by anticipated listings and portfolio gains. Key holdings like Peninsula Capital and California Nanotechnologies are positioned for growth.
Quinsam Capital Report: Q2 2026
Quinsam Capital published a report on August 17, 2026 containing material business information for investors and shareholders.
Quinsam Capital MD&A: Q2 2026
Quinsam Capital filed a regulatory document on August 17, 2026 disclosing important business information.
Quinsam Capital Earnings release: Q2 2026
Quinsam Capital released its Q2 2026 earnings on August 17, 2026, summarizing the period's financial results.
Quinsam Grants Options
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION BY ANY UNITED STATES NEWS DISTRIBUTION SERVICE Toronto, Ontario--(Newsfile Corp. - June 15, 2026) - Quinsam Capital Corporation (CSE: QCA...
Quinsam Capital Earnings Call Transcript: Q1 2026
NAV rose by over CAD 1 million in Q1, driven by strong mining investments and a profitable exit from oil and gas. Key upcoming catalysts include Peninsula's listing and potential commercial contracts in the nuclear sector, with continued positive NAV trends.
Quinsam Capital MD&A: Q1 2026
Quinsam Capital filed a regulatory document on May 20, 2026 disclosing important business information.
Quinsam Capital Report: Q1 2026
Quinsam Capital published a report on May 20, 2026 containing material business information for investors and shareholders.
Quinsam Capital Earnings release: Q1 2026
Quinsam Capital released its Q1 2026 earnings on May 20, 2026, summarizing the period's financial results.
Quinsam Announces Q1/2026 Results
Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - Quinsam Capital Corporation (CSE: QCA) ("Quinsam" or the "Company") is announcing its Q1/2026 results, with net income of $1.4 million ($0.015 per s...
Quinsam Capital Earnings Call Transcript: Q4 2025
Q4 closed with a small profit and NAV at CAD 0.10, with further NAV growth expected in Q1 due to strong public equity performance. Key investments in Deep Sea Minerals, Nevada Organic Phosphate, and Peninsula contributed to gains, while new opportunities like Bond Intelligence are being explored.
Quinsam Capital Earnings release: Q4 2025
Quinsam Capital released its Q4 2025 earnings on April 28, 2026, summarizing the period's financial results.
Quinsam Capital Report: Q4 2025
Quinsam Capital published a report on April 28, 2026 containing material business information for investors and shareholders.
Quinsam Capital MD&A: Q4 2025
Quinsam Capital filed a regulatory document on April 28, 2026 disclosing important business information.
Quinsam Reports Q4/2025 Results
Toronto, Ontario--(Newsfile Corp. - April 27, 2026) - Quinsam Capital Corporation (CSE: QCA) ("Quinsam" or the "Company") is announcing its Q4/2025 results, with net income of $0.4 million ($0.01 per ...
Quinsam Capital Earnings Call Transcript: Q3 2025
Q3 saw a small profit with limited activity, but Q4 could bring significant NAV growth if key private investments complete public listings. Notable developments include clinical progress at Asynaptic and a conservative write-down of Newlox Gold, with market volatility remaining a factor.
Quinsam Capital Earnings release: Q3 2025
Quinsam Capital released its Q3 2025 earnings on November 14, 2025, summarizing the period's financial results.
Quinsam Capital MD&A: Q3 2025
Quinsam Capital filed a regulatory document on November 14, 2025 disclosing important business information.
Quinsam Capital Report: Q3 2025
Quinsam Capital published a report on November 14, 2025 containing material business information for investors and shareholders.
Quinsam Reports Q3/2025 Results
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Quinsam Capital Corporation (CSE: QCA) ("Quinsam" or the "Company") is announcing its Q3/2025 results, with net income of $0.1 million ($0.00 p...